Middle East and Africa Botulinum Toxin Market Size and Forecasts (2020 - 2030), Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Botox, Dysport, Xeomin, and Others), Application (Medical and Aesthetic), and End User (Specialty and Dermatology Clinics, Hospitals and Clinics, and Others)
The Middle East and Africa botulinum toxin market size is expected to reach US$ 453.55 million by 2030 from US$ 172.57 million in 2022. The market is estimated to grow at a CAGR of 12.8% from 2022 to 2030.
The global botulinum toxin market, by application, is segmented into medical and aesthetics. The medical segment held the largest share of the market in 2022 and is expected to retain its dominance during the forecast period.
Botulinum toxin is a drug used to treat and manage a variety of therapeutic and aesthetic conditions. Chronic migraine, spastic disorders, cervical dystonia, and detrusor hyperactivity are all examples of medicinal usage.t is in the neurotoxin class of medications. This activity reviews the indications, action, and contraindications for botulinum toxin therapy as a valuable agent for therapeutic and cosmetic treatment in the clinical setting. The medical segment in the botulinum toxin market is sub-segmented as chronic migraine (CM), muscle spasm, overreactive bladder, hyperhidrosis, and others. In 2010, the Food and Drug Administration (FDA) of the United States approved onabotulinumtoxinA (Botox) as a prophylactic treatment for CM. OnabotulinumtoxinA is beneficial in reducing the frequency and severity of headaches in people with CM. Furthermore, the Aesthetic segment is sub-segmented into crow’s feet, forehead lines, frown lines/ glabellar, square jaw/ masseter, and others.
By product, the Middle East and Africa botulinum toxin market is segmented into Botox, Dysport Xeomin, and others. The botulinum toxin market, by end-user, the market is fragmented into hospitals and clinics, specialty and dermatology clinics, and others. The specialty and dermatology clinics segment held the largest share of the market in 2022 and is anticipated to register the highest CAGR in the market during the forecast period.
Based on country, the Middle East and Africa botulinum toxin market is divided into Saudi Arabia, UAE, South Africa, Lebanon, Oman, Jordan, Qatar, Kuwait, Bahrain, and the Rest of the Middle East and Africa. Lebanon is well known for its cosmetic surgeries, and the number of aesthetic procedures is expanding in Lebanon, where treatments like dermal fillers (DFs) hold a major share in the anti-aging industry. Furthermore, the rapid global development of the pharmacy profession has also led pharmacists to enter the cosmetic industry by administering injectable DFs to those in need. According to TRT World, in 2020, Lebanon was recognized long time ago as the Botox capital of the Middle East region. The increasing demand for less aggressive or invasive aesthetic procedures, particularly those with short duration and quick recovery, has created opportunities for pharmacists to practice their clinical expertise in this regard. This small Middle Eastern country has one of the highest pharmacists-to-population ratios in the world. However, the pharmacy profession is still constantly evolving and entering into many fields. Therefore, various legislative procedures, training, licensing, and developed pharmacy curricula are very necessary prior to the practice of DFs by pharmacists in Lebanon.
Botulinum toxin treatments are the most common and most popular wrinkle treatments in Lebanon. Botulinum toxin injections of the lower face and neck are useful, simple, and safe procedures that should be part of every aesthetic practitioner's arsenal. Various clinics in Lebanon provide Botox treatments, some of them are namely Dr Andre Chraim - Plastic Surgery and Elie Melhem Clinc. The Elie Melhem Clinic, located in Mansouriyeh, Beirut, Lebanon, offers patients Botox Injections procedures among its total of 24 available procedures across 9 different specialties. A Botox Injection procedure costs from US$ 400 to US$ 496, whilst the national average price is approximately US$ 350. Many specialists are available at the Clinic, and they are accredited by International Organization for Standardization (ISO) Certification.
Therefore, the aforementioned factors are expected to boost the market growth in the country.
The botulinum toxin market majorly consists of the players such as AbbVie Inc., Merz Pharma, Medytox, Sanofi, Ipsen Pharma, Galderma, Revance Therapeutics Inc., Lanzhou Institute of Biological Products Co., Ltd., Candela Medical, and Daewoong Pharmaceutical Co. Ltd. amongst others.
The World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), Health Education England (HEE), Dubai Health Authority, Government of Dubai Media Office (GDMO), National Institute for Health and Care Excellence (NICE), and Therapeutic Goods Administration (TGA) are a few key primary and secondary sources referred to while preparing the report on the neurotoxin market.
The global botulinum toxin market, by application, is segmented into medical and aesthetics. The medical segment held the largest share of the market in 2022 and is expected to retain its dominance during the forecast period.
Botulinum toxin is a drug used to treat and manage a variety of therapeutic and aesthetic conditions. Chronic migraine, spastic disorders, cervical dystonia, and detrusor hyperactivity are all examples of medicinal usage.t is in the neurotoxin class of medications. This activity reviews the indications, action, and contraindications for botulinum toxin therapy as a valuable agent for therapeutic and cosmetic treatment in the clinical setting. The medical segment in the botulinum toxin market is sub-segmented as chronic migraine (CM), muscle spasm, overreactive bladder, hyperhidrosis, and others. In 2010, the Food and Drug Administration (FDA) of the United States approved onabotulinumtoxinA (Botox) as a prophylactic treatment for CM. OnabotulinumtoxinA is beneficial in reducing the frequency and severity of headaches in people with CM. Furthermore, the Aesthetic segment is sub-segmented into crow’s feet, forehead lines, frown lines/ glabellar, square jaw/ masseter, and others.
By product, the Middle East and Africa botulinum toxin market is segmented into Botox, Dysport Xeomin, and others. The botulinum toxin market, by end-user, the market is fragmented into hospitals and clinics, specialty and dermatology clinics, and others. The specialty and dermatology clinics segment held the largest share of the market in 2022 and is anticipated to register the highest CAGR in the market during the forecast period.
Based on country, the Middle East and Africa botulinum toxin market is divided into Saudi Arabia, UAE, South Africa, Lebanon, Oman, Jordan, Qatar, Kuwait, Bahrain, and the Rest of the Middle East and Africa. Lebanon is well known for its cosmetic surgeries, and the number of aesthetic procedures is expanding in Lebanon, where treatments like dermal fillers (DFs) hold a major share in the anti-aging industry. Furthermore, the rapid global development of the pharmacy profession has also led pharmacists to enter the cosmetic industry by administering injectable DFs to those in need. According to TRT World, in 2020, Lebanon was recognized long time ago as the Botox capital of the Middle East region. The increasing demand for less aggressive or invasive aesthetic procedures, particularly those with short duration and quick recovery, has created opportunities for pharmacists to practice their clinical expertise in this regard. This small Middle Eastern country has one of the highest pharmacists-to-population ratios in the world. However, the pharmacy profession is still constantly evolving and entering into many fields. Therefore, various legislative procedures, training, licensing, and developed pharmacy curricula are very necessary prior to the practice of DFs by pharmacists in Lebanon.
Botulinum toxin treatments are the most common and most popular wrinkle treatments in Lebanon. Botulinum toxin injections of the lower face and neck are useful, simple, and safe procedures that should be part of every aesthetic practitioner's arsenal. Various clinics in Lebanon provide Botox treatments, some of them are namely Dr Andre Chraim - Plastic Surgery and Elie Melhem Clinc. The Elie Melhem Clinic, located in Mansouriyeh, Beirut, Lebanon, offers patients Botox Injections procedures among its total of 24 available procedures across 9 different specialties. A Botox Injection procedure costs from US$ 400 to US$ 496, whilst the national average price is approximately US$ 350. Many specialists are available at the Clinic, and they are accredited by International Organization for Standardization (ISO) Certification.
Therefore, the aforementioned factors are expected to boost the market growth in the country.
The botulinum toxin market majorly consists of the players such as AbbVie Inc., Merz Pharma, Medytox, Sanofi, Ipsen Pharma, Galderma, Revance Therapeutics Inc., Lanzhou Institute of Biological Products Co., Ltd., Candela Medical, and Daewoong Pharmaceutical Co. Ltd. amongst others.
The World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), Health Education England (HEE), Dubai Health Authority, Government of Dubai Media Office (GDMO), National Institute for Health and Care Excellence (NICE), and Therapeutic Goods Administration (TGA) are a few key primary and secondary sources referred to while preparing the report on the neurotoxin market.
1. INTRODUCTION
1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness Analysis
3. RESEARCH METHODOLOGY
4. BOTULINUM TOXIN MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
4.3.1 List of Vendors in the Value Chain
5. BOTULINUM TOXIN MARKET - KEY MARKET DYNAMICS
5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints
6. BOTULINUM TOXIN MARKET - MIDDLE EAST AND AFRICA MARKET ANALYSIS
6.1 Botulinum Toxin - Middle East and Africa Market Overview
6.2 Botulinum Toxin - Middle East and Africa Market and Forecast to 2030
7. BOTULINUM TOXIN MARKET – REVENUE ANALYSIS (USD MILLION) – BY PRODUCT, 2020-2030
7.1 Overview
7.2 Botox
7.3 Dysport
7.4 Xeomin
7.5 Others
8. BOTULINUM TOXIN MARKET – REVENUE ANALYSIS (USD MILLION) – BY APPLICATION, 2020-2030
8.1 Overview
8.2 Medical
8.2.1 Chronic Migraine
8.2.2 Muscle Spasm
8.2.3 Over Reactive Bladder
8.2.4 Hyperhidrosis
8.2.5 Others
8.3 Aesthetic
8.3.1 Crow’s Feet
8.3.2 Forehead Lines
8.3.3 Frown Lines/ Glabellar
8.3.4 Square Jaw/ Masseter
8.3.5 Others
9. BOTULINUM TOXIN MARKET – REVENUE ANALYSIS (USD MILLION) – BY END USER, 2020-2030
9.1 Overview
9.2 Specialty and Dermatology Clinics
9.3 Hospitals and Clinics
9.4 Others
10. BOTULINUM TOXIN MARKET - REVENUE ANALYSIS (USD MILLION), 2020-2030 – COUNTRY ANALYSIS
10.1 Middle East and Africa
10.1.1 Middle East and Africa Botulinum Toxin Market Overview
10.1.2 Middle East and Africa Botulinum Toxin Market Revenue and Forecasts to 2030
10.1.3 Middle East and Africa Botulinum Toxin Market Revenue and Forecasts and Analysis - By Product
10.1.4 Middle East and Africa Botulinum Toxin Market Revenue and Forecasts and Analysis - By Application
10.1.5 Middle East and Africa Botulinum Toxin Market Revenue and Forecasts and Analysis - By End User
10.1.6 Middle East and Africa Botulinum Toxin Market Revenue and Forecasts and Analysis - By Countries
10.1.6.1 South Africa Botulinum Toxin Market
10.1.6.1.1 South Africa Botulinum Toxin Market, by Product
10.1.6.1.2 South Africa Botulinum Toxin Market, by Application
10.1.6.1.3 South Africa Botulinum Toxin Market, by End User
10.1.6.2 Saudi Arabia Botulinum Toxin Market
10.1.6.2.1 Saudi Arabia Botulinum Toxin Market, by Product
10.1.6.2.2 Saudi Arabia Botulinum Toxin Market, by Application
10.1.6.2.3 Saudi Arabia Botulinum Toxin Market, by End User
10.1.6.3 U.A.E Botulinum Toxin Market
10.1.6.3.1 U.A.E Botulinum Toxin Market, by Product
10.1.6.3.2 U.A.E Botulinum Toxin Market, by Application
10.1.6.3.3 U.A.E Botulinum Toxin Market, by End User
10.1.6.4 Lebanon Botulinum Toxin Market
10.1.6.4.1 Lebanon Botulinum Toxin Market, by Product
10.1.6.4.2 Lebanon Botulinum Toxin Market, by Application
10.1.6.4.3 Lebanon Botulinum Toxin Market, by End User
10.1.6.5 Kuwait Botulinum Toxin Market
10.1.6.5.1 Kuwait Botulinum Toxin Market, by Product
10.1.6.5.2 Kuwait Botulinum Toxin Market, by Application
10.1.6.5.3 Kuwait Botulinum Toxin Market, by End User
10.1.6.6 Qatar Botulinum Toxin Market
10.1.6.6.1 Qatar Botulinum Toxin Market, by Product
10.1.6.6.2 Qatar Botulinum Toxin Market, by Application
10.1.6.6.3 Qatar Botulinum Toxin Market, by End User
10.1.6.7 Jordan Botulinum Toxin Market
10.1.6.7.1 Jordan Botulinum Toxin Market, by Product
10.1.6.7.2 Jordan Botulinum Toxin Market, by Application
10.1.6.7.3 Jordan Botulinum Toxin Market, by End User
10.1.6.8 Bahrain Botulinum Toxin Market
10.1.6.8.1 Bahrain Botulinum Toxin Market, by Product
10.1.6.8.2 Bahrain Botulinum Toxin Market, by Application
10.1.6.8.3 Bahrain Botulinum Toxin Market, by End User
10.1.6.9 Oman Botulinum Toxin Market
10.1.6.9.1 Oman Botulinum Toxin Market, by Product
10.1.6.9.2 Oman Botulinum Toxin Market, by Application
10.1.6.9.3 Oman Botulinum Toxin Market, by End User
10.1.6.10 Rest of Middle East and Africa Botulinum Toxin Market
10.1.6.10.1 Rest of Middle East and Africa Botulinum Toxin Market, by Product
10.1.6.10.2 Rest of Middle East and Africa Botulinum Toxin Market, by Application
10.1.6.10.3 Rest of Middle East and Africa Botulinum Toxin Market, by End User
11. INDUSTRY LANDSCAPE
11.1 Mergers and Acquisitions
11.2 Agreements, Collaborations, Joint Ventures
11.3 New Product Launches
11.4 Expansions and Other Strategic Developments
12. COMPETITIVE LANDSCAPE
12.1 Heat Map Analysis by Key Players
12.2 Company Positioning and Concentration
13. BOTULINUM TOXIN MARKET - KEY COMPANY PROFILES
13.1 AbbVie Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
Note - Similar information would be provided for below list of companies
13.2 Merz Pharma
13.3 Aquavit Holdings
13.4 OCEAN PHARMACEUTICAL
13.5 Daewoong Pharmaceuticals
13.6 Medytox Inc.
13.7 GALDERMA
13.8 Onco India International
13.9 Ipsen Pharma
13.10 Sisram Medical Ltd
14. APPENDIX
14.1 Glossary
14.2 About The Insight Partners
14.3 Market Intelligence Cloud
1.1 Scope of the Study
1.2 Market Definition, Assumptions and Limitations
1.3 Market Segmentation
2. EXECUTIVE SUMMARY
2.1 Key Insights
2.2 Market Attractiveness Analysis
3. RESEARCH METHODOLOGY
4. BOTULINUM TOXIN MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.3 Ecosystem Analysis
4.3.1 List of Vendors in the Value Chain
5. BOTULINUM TOXIN MARKET - KEY MARKET DYNAMICS
5.1 Key Market Drivers
5.2 Key Market Restraints
5.3 Key Market Opportunities
5.4 Future Trends
5.5 Impact Analysis of Drivers and Restraints
6. BOTULINUM TOXIN MARKET - MIDDLE EAST AND AFRICA MARKET ANALYSIS
6.1 Botulinum Toxin - Middle East and Africa Market Overview
6.2 Botulinum Toxin - Middle East and Africa Market and Forecast to 2030
7. BOTULINUM TOXIN MARKET – REVENUE ANALYSIS (USD MILLION) – BY PRODUCT, 2020-2030
7.1 Overview
7.2 Botox
7.3 Dysport
7.4 Xeomin
7.5 Others
8. BOTULINUM TOXIN MARKET – REVENUE ANALYSIS (USD MILLION) – BY APPLICATION, 2020-2030
8.1 Overview
8.2 Medical
8.2.1 Chronic Migraine
8.2.2 Muscle Spasm
8.2.3 Over Reactive Bladder
8.2.4 Hyperhidrosis
8.2.5 Others
8.3 Aesthetic
8.3.1 Crow’s Feet
8.3.2 Forehead Lines
8.3.3 Frown Lines/ Glabellar
8.3.4 Square Jaw/ Masseter
8.3.5 Others
9. BOTULINUM TOXIN MARKET – REVENUE ANALYSIS (USD MILLION) – BY END USER, 2020-2030
9.1 Overview
9.2 Specialty and Dermatology Clinics
9.3 Hospitals and Clinics
9.4 Others
10. BOTULINUM TOXIN MARKET - REVENUE ANALYSIS (USD MILLION), 2020-2030 – COUNTRY ANALYSIS
10.1 Middle East and Africa
10.1.1 Middle East and Africa Botulinum Toxin Market Overview
10.1.2 Middle East and Africa Botulinum Toxin Market Revenue and Forecasts to 2030
10.1.3 Middle East and Africa Botulinum Toxin Market Revenue and Forecasts and Analysis - By Product
10.1.4 Middle East and Africa Botulinum Toxin Market Revenue and Forecasts and Analysis - By Application
10.1.5 Middle East and Africa Botulinum Toxin Market Revenue and Forecasts and Analysis - By End User
10.1.6 Middle East and Africa Botulinum Toxin Market Revenue and Forecasts and Analysis - By Countries
10.1.6.1 South Africa Botulinum Toxin Market
10.1.6.1.1 South Africa Botulinum Toxin Market, by Product
10.1.6.1.2 South Africa Botulinum Toxin Market, by Application
10.1.6.1.3 South Africa Botulinum Toxin Market, by End User
10.1.6.2 Saudi Arabia Botulinum Toxin Market
10.1.6.2.1 Saudi Arabia Botulinum Toxin Market, by Product
10.1.6.2.2 Saudi Arabia Botulinum Toxin Market, by Application
10.1.6.2.3 Saudi Arabia Botulinum Toxin Market, by End User
10.1.6.3 U.A.E Botulinum Toxin Market
10.1.6.3.1 U.A.E Botulinum Toxin Market, by Product
10.1.6.3.2 U.A.E Botulinum Toxin Market, by Application
10.1.6.3.3 U.A.E Botulinum Toxin Market, by End User
10.1.6.4 Lebanon Botulinum Toxin Market
10.1.6.4.1 Lebanon Botulinum Toxin Market, by Product
10.1.6.4.2 Lebanon Botulinum Toxin Market, by Application
10.1.6.4.3 Lebanon Botulinum Toxin Market, by End User
10.1.6.5 Kuwait Botulinum Toxin Market
10.1.6.5.1 Kuwait Botulinum Toxin Market, by Product
10.1.6.5.2 Kuwait Botulinum Toxin Market, by Application
10.1.6.5.3 Kuwait Botulinum Toxin Market, by End User
10.1.6.6 Qatar Botulinum Toxin Market
10.1.6.6.1 Qatar Botulinum Toxin Market, by Product
10.1.6.6.2 Qatar Botulinum Toxin Market, by Application
10.1.6.6.3 Qatar Botulinum Toxin Market, by End User
10.1.6.7 Jordan Botulinum Toxin Market
10.1.6.7.1 Jordan Botulinum Toxin Market, by Product
10.1.6.7.2 Jordan Botulinum Toxin Market, by Application
10.1.6.7.3 Jordan Botulinum Toxin Market, by End User
10.1.6.8 Bahrain Botulinum Toxin Market
10.1.6.8.1 Bahrain Botulinum Toxin Market, by Product
10.1.6.8.2 Bahrain Botulinum Toxin Market, by Application
10.1.6.8.3 Bahrain Botulinum Toxin Market, by End User
10.1.6.9 Oman Botulinum Toxin Market
10.1.6.9.1 Oman Botulinum Toxin Market, by Product
10.1.6.9.2 Oman Botulinum Toxin Market, by Application
10.1.6.9.3 Oman Botulinum Toxin Market, by End User
10.1.6.10 Rest of Middle East and Africa Botulinum Toxin Market
10.1.6.10.1 Rest of Middle East and Africa Botulinum Toxin Market, by Product
10.1.6.10.2 Rest of Middle East and Africa Botulinum Toxin Market, by Application
10.1.6.10.3 Rest of Middle East and Africa Botulinum Toxin Market, by End User
11. INDUSTRY LANDSCAPE
11.1 Mergers and Acquisitions
11.2 Agreements, Collaborations, Joint Ventures
11.3 New Product Launches
11.4 Expansions and Other Strategic Developments
12. COMPETITIVE LANDSCAPE
12.1 Heat Map Analysis by Key Players
12.2 Company Positioning and Concentration
13. BOTULINUM TOXIN MARKET - KEY COMPANY PROFILES
13.1 AbbVie Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
Note - Similar information would be provided for below list of companies
13.2 Merz Pharma
13.3 Aquavit Holdings
13.4 OCEAN PHARMACEUTICAL
13.5 Daewoong Pharmaceuticals
13.6 Medytox Inc.
13.7 GALDERMA
13.8 Onco India International
13.9 Ipsen Pharma
13.10 Sisram Medical Ltd
14. APPENDIX
14.1 Glossary
14.2 About The Insight Partners
14.3 Market Intelligence Cloud
